for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Immunic Announces FDA Allowance Of Its Phase 2, Calvid-1 Clinical Trial Of Imu-838 In Covid-19

June 9 (Reuters) - Immunic Inc:

* IMMUNIC, INC. ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION ALLOWANCE OF ITS PHASE 2, CALVID-1 CLINICAL TRIAL OF IMU-838 IN COVID-19 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up